Lack of evidence raises questions on long-term PPI use
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
Case study: Uncovering Josef’s asthma flare-ups
If your patient is experiencing an increase in the frequency or severity of asthma symptoms or an increased reliance on their asthma inhaler, allergies could be the hidden cause.
The PSA26 social circuit: dress up and let your hair down
Along with the panels, plenaries, and presentations, PSA delegates have a packed social calendar. This year’s conference offered attendees a rich variety of opportunities...
Pharmacists’ vaccination value adds up to saved lives
Federal Health Minister Greg Hunt has praised pharmacists’ role in saving lives through expanded vaccinations in community pharmacies, and undertaken to pressure states to...
From the President: PSA at the FIP World Congress in Seville,...
I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...
